# Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

> **NCT01484262** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 1344 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** insulin

## Key facts

- **NCT ID:** NCT01484262
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-14
- **Primary completion:** 2014-10-31
- **Final completion:** 2014-10-31
- **Target enrollment:** 1344 (ACTUAL)
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484262, "Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01484262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*